Raymond James analyst James Rollyson raised the firm’s price target on Archrock (AROC) to $46 from $40 and keeps an Outperform rating on the shares. The quarter was broadly positive with compression contract operations outperforming expectations despite asset sales, AMS revenue coming in slightly below estimates due to seasonal variability, and consolidated adjusted EBITDA finishing about 2% ahead of consensus, alongside continued strong free cash flow generation and ongoing shareholder returns through an increased dividend and share repurchases exceeding half of quarterly free cash flow, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AROC:
